Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
Memo Therapeutics

Memo Therapeutics

Memo Therapeutics is an antibody Discovery Technology founded in 2012.

OverviewStructured DataIssuesContributorsActivity
Is a
Organization
Organization
Company
Company
B2X
B2B
B2B
Company Operating Status
Active
Country
Switzerland
Switzerland
Email Address
info@memo-therapeutics.com
0
Founded Date
January 1, 2012
Full Address
Wagistrasse 27 8952 Schlieren / Zurich Switzerland
0
Headquarters
Zürich
Zürich
Industry
‌
CAR T-Cell therapy
Immunotherapy
Immunotherapy
Cell therapy
Cell therapy
Engineering
Engineering
Biomedical engineering
Biomedical engineering
Drug discovery
Drug discovery
Health technology
Health technology
Cell biology
Cell biology
Single-cell analysis
Single-cell analysis
Biotechnology
Biotechnology
Investors
Fresenius Medical Care Ventures
Fresenius Medical Care Ventures
EVA Basel
EVA Basel
Swisscanto Private Equity
Swisscanto Private Equity
Fresenius Medical Care
Fresenius Medical Care
Pureos Bioventures
Pureos Bioventures
Adjuvant Capital
Adjuvant Capital
Verve Ventures
Verve Ventures
Latest Funding Round Date
November 2, 2023
Latest Funding Round Amount (USD)
28,000,000
Latest Funding Type
Series C
Series C
LinkedIn URL
@company/memo-therapeutics-ag
Location
Switzerland
Switzerland
Schlieren, Switzerland
Schlieren, Switzerland
0
Number of Employees (Ranges)
11 – 50
Patents Assigned (Count)
1
Phone Number
+41445159140
0
Pitchbook URL
pitchbook.com/profiles...120609-19
Total Funding Amount (USD)
83,600,000
Official Website
memo-therapeutics.com

Find more companies like Memo Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.